Complex noradrenergic dysfunction in Alzheimer's disease: Low norepinephrine input is not always to blame
- PMID: 29307592
- PMCID: PMC6855395
- DOI: 10.1016/j.brainres.2018.01.001
Complex noradrenergic dysfunction in Alzheimer's disease: Low norepinephrine input is not always to blame
Abstract
The locus coeruleus-noradrenergic (LC-NA) system supplies the cerebral cortex with norepinephrine, a key modulator of cognition. Neurodegeneration of the LC is an early hallmark of Alzheimer's disease (AD). In this article, we analyze current literature to understand whether NA degeneration in AD simply leads to a loss of norepinephrine input to the cortex. With reported adaptive changes in the LC-NA system at the anatomical, cellular, and molecular levels in AD, existing evidence support a seemingly sustained level of extracellular NE in the cortex, at least at early stages of the long course of AD. We postulate that loss of the integrity of the NA system, rather than mere loss of NE input, is a key contributor to AD pathogenesis. A thorough understanding of NA dysfunction in AD has a large impact on both our comprehension and treatment of this devastating disease.
Keywords: Alzheimer’s disease; Dysfunction; Locus coeruleus; Noradrenergic; Norepinephrine.
Copyright © 2018 Elsevier B.V. All rights reserved.
Similar articles
-
Assessing disease-modifying effects of norepinephrine in Down syndrome and Alzheimer's disease.Brain Res. 2019 Jan 1;1702:3-11. doi: 10.1016/j.brainres.2017.09.035. Epub 2017 Nov 8. Brain Res. 2019. PMID: 29102776 Review.
-
Early Locus Coeruleus noradrenergic axon loss drives olfactory dysfunction in Alzheimer's disease.Nat Commun. 2025 Aug 8;16(1):7338. doi: 10.1038/s41467-025-62500-8. Nat Commun. 2025. PMID: 40781079 Free PMC article.
-
Heightened Hippocampal β-Adrenergic Receptor Function Drives Synaptic Potentiation and Supports Learning and Memory in the TgF344-AD Rat Model during Prodromal Alzheimer's Disease.J Neurosci. 2021 Jun 30;41(26):5747-5761. doi: 10.1523/JNEUROSCI.0119-21.2021. Epub 2021 May 5. J Neurosci. 2021. PMID: 33952633 Free PMC article.
-
Impact of noradrenergic inhibition on neuroinflammation and pathophysiology in mouse models of Alzheimer's disease.J Neuroinflammation. 2024 Dec 18;21(1):322. doi: 10.1186/s12974-024-03306-1. J Neuroinflammation. 2024. PMID: 39696597 Free PMC article.
-
The Cholinergic System, the Adrenergic System and the Neuropathology of Alzheimer's Disease.Int J Mol Sci. 2021 Jan 28;22(3):1273. doi: 10.3390/ijms22031273. Int J Mol Sci. 2021. PMID: 33525357 Free PMC article. Review.
Cited by
-
Profiling Chemobiological Connection between Natural Product and Target Space Based on Systematic Analysis.Int J Mol Sci. 2023 Jul 10;24(14):11265. doi: 10.3390/ijms241411265. Int J Mol Sci. 2023. PMID: 37511025 Free PMC article.
-
Noradrenergic Modulation of the Piriform Cortex: A Possible Avenue for Understanding Pre-Clinical Alzheimer's Disease Pathogenesis.Front Cell Neurosci. 2022 May 26;16:908758. doi: 10.3389/fncel.2022.908758. eCollection 2022. Front Cell Neurosci. 2022. PMID: 35722616 Free PMC article. Review.
-
Deciphering the Role of Adrenergic Receptors in Alzheimer's Disease: Paving the Way for Innovative Therapies.Biomolecules. 2025 Jan 15;15(1):128. doi: 10.3390/biom15010128. Biomolecules. 2025. PMID: 39858522 Free PMC article. Review.
-
New approaches for the quantification and targeting of noradrenergic dysfunction in Alzheimer's disease.Ann Clin Transl Neurol. 2022 Apr;9(4):582-596. doi: 10.1002/acn3.51539. Epub 2022 Mar 15. Ann Clin Transl Neurol. 2022. PMID: 35293158 Free PMC article. Review.
-
Beyond the brain: early autonomic dysfunction in Alzheimer's disease.Acta Neuropathol Commun. 2025 Jun 10;13(1):128. doi: 10.1186/s40478-025-02042-8. Acta Neuropathol Commun. 2025. PMID: 40495232 Free PMC article.
References
-
- Adolfsson R et al., 1979. Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br. J. Psychiatry 135, 216–223. - PubMed
-
- Arnsten AF, Jentsch JD, 1997. The alpha-1 adrenergic agonist, cirazoline, impairs spatial working memory performance in aged monkeys. Pharmacol. Biochem. Behav 58, 55–59. - PubMed
-
- Arnsten AF, 1998. The biology of being frazzled. Science 280, 1711–1712. - PubMed
-
- Arnsten AF, Goldman-Rakic PS, 1998. Noise stress impairs prefrontal cortical cognitive function in monkeys: evidence for a hyperdopaminergic mechanism. Arch. Gen. Psychiatry 55, 362–368. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials